Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
Sales | 1,059,000 | 0 | 0 | 0 | 0 |
Cost of Goods | 371,500 | N/A | N/A | N/A | N/A |
Gross Profit | 687,500 | N/A | N/A | N/A | N/A |
Operating Expenses | 392,700 | 0 | 0 | 0 | 0 |
Operating Income | 295,300 | N/A | N/A | N/A | N/A |
Interest Expense | 13,600 | 0 | 0 | 0 | 0 |
Other Income | 24,500 | 0 | 0 | 0 | 0 |
Pre-tax Income | 306,200 | 0 | 0 | 0 | 0 |
Income Tax | 101,000 | N/A | N/A | N/A | N/A |
Net Income Continuous | 205,200 | N/A | N/A | N/A | N/A |
Net Income | $205,200 | $N/A | $N/A | $N/A | $N/A |
EBITDA(a) | $295,300 | $N/A | $N/A | $N/A | $N/A |